Lucas Sabatella MD, PhD

General and Upper GI surgery

[The Obesity Society @ObesitySociety]

Metabolic surgery outperforms GLP-1 agonists in weight loss and diabetes remission; tirzepatide narrows this gap. Read more in Obesity: https://t.co/N7K3431hjk #BariatricSurgery #GLP1 #ObesityResearch @lucassabatella

[CUN Surgery @cun_surgery]

A small milestone for our department:
🔔 more than 3,150 laparoscopic inguinal hernia repairs performed!
✔️ Minimally invasive surgery
✔️ Faster recovery
✔️ Extensive surgical experience

Always learning. Always improving. 🩹🥼
#surgery #hernia #laparoscopy #MinimallyInvasive

[Obesity Surgery Journal @JournalObesity]

📖Read the full article here: https://t.co/JbMdUZMK4b
@LucasSabatella @PatMOrtega @RotellarSastre @CarlotaTuero @Nuuur21 @AdrianaUrizP1 @AzcarateValenti @IfsoSecretariat @ASMBS @ScottShikoraMD @rvcohen @AartsEdo @TROGSS_official @ItalicBoldDKR @ProfessorYitka
🧵2/2

[Obesity Surgery Journal @JournalObesity]

🎥Our latest Top 10 Article-of-Interest "Brief Interview" is posted on our YouTube Channel!
🤔Dr Oviedo interviews Top-10 author Dr. Lucas Sabatella about this fascinating published article.
📺Watch it here: https://t.co/8lqOt9xJm1
🧵1/

[CUN Surgery @cun_surgery]

📍Borderline PDAC case:
⚡️FOLFIRINOX x 4
📊 CT suggests contact with SMA, SMV and left renal vein

Taken to OR ➡️ No vascular reconstruction needed
(📷 images attached)

#HPBSurgery #PancreaticCancer #SurgicalDecisionMaking

[Víctor Valentí @doctorValenti]

Congratulations team @cun_surgery @ClinicaNavarra Renewal as a Center of Excellence in Bariatric and Metabolic Surgery EAC-BS @ifso_ec

[CUN Surgery @cun_surgery]

🆕📢 Just published in Obesity Surgery! Our meta-analysis published by @LucasSabatella et al.
of #SADI-S vs #RYGB:
✅ More weight loss
✅ Higher T2D remission
✅ Fewer complications (BMI <50)

SADI-S shows strong advantages in selected patients.
🔗https://t.co/UJKqH7MkqJ
#obesity

[CUN Surgery @cun_surgery]

🔥 New insights from the OR 🔥

🔎Recently published @AnnSurgOncol

📽️Watch our new latest minimally invasive approach, by our HPB Unit! Now available on full video ⬇️

https://t.co/VhPIuWV5xx

@NuriaBlancoa @da_aliseda @LucasSabatella @ClinicaNavarra

[Ricardo Cohen @rvcohen]

IFSO statement@Lancet DE: Med-induced WL isn't a reason to delay bariatric surgery. Many stop meds due to cost, intolerance, or wanting a "definitive" fix. Clinicians must not wait for the predictable relapse of complications. The goal is sustained health, not temporary metrics

[IFSO @IfsoSecretariat]

July issue of @JournalObesity is out!!
#5SysRev, #1RCT, #Longterm_LSG, #Abdominal_pain, #OAGB_after_LAGB, #DATO, #Fascial_Closure, #Same_day_discharge, #Banded_OAGB, #Virtual_FU, #AI_nausea, #Preoperative_endoscopy, #Stents_strincture & much more on:

https://t.co/eHyEqCCGnZ

[CUN Surgery @cun_surgery]

Volvemos del #CNC2024 @cnaec2024 contentos tras unos días rodeados de amigos y compañeros. Representando @cun_surgery con distintas comunicaciones y ponencias! Regresamos con nuevas ideas 💡 con un premio y una beca para seguir trabajando 💪🏽

[Clínica Universidad de Navarra @ClinicaNavarra]

Enhorabuena a @LucasSabatella, residente de @cun_surgery y ganador de la beca internacional de @IfsoSecretariat en el 13th Congreso de esta federación internacional. Se otorgan 5 en el mundo, en base al #curriculum del aspirante y la calidad de los trabajos presentados 👏

[CUN Surgery @cun_surgery]

Long-term outcomes after HOPE and LT of 1,202 donor livers in a real-world setting (HOPE-REAL study)

🇪🇺 22 centres

🤯5-y graft survival > 80% in high-risk futile DCD
🔥Excellent 5-y OS in DBD and DCD

HOPE is all we need?
@JHepatology #LiverTwitter

🔗https://t.co/aCaLELf7zV